Titan Biotech Limited (BOM:524717)
India flag India · Delayed Price · Currency is INR
1,212.15
+74.25 (6.53%)
At close: Feb 13, 2026

Titan Biotech Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
10,0173,4844,3651,6272,1661,533
Market Cap Growth
65.54%-20.19%168.33%-24.88%41.23%335.05%
Enterprise Value
10,0693,4094,4051,6652,3811,592
Last Close Price
1212.15420.64525.45194.81257.96181.86
PE Ratio
36.8316.1817.566.559.995.06
PS Ratio
5.202.232.661.131.751.08
PB Ratio
6.022.273.271.482.512.12
P/TBV Ratio
6.022.273.271.482.512.23
P/FCF Ratio
-32.39262.7219.2613.779.54
P/OCF Ratio
-17.3120.647.689.828.04
EV/Sales Ratio
5.232.182.691.161.931.12
EV/EBITDA Ratio
27.8313.7513.095.767.743.46
EV/EBIT Ratio
32.0816.1514.306.218.263.60
EV/FCF Ratio
-31.70265.1319.7215.149.91
Debt / Equity Ratio
0.050.020.070.080.100.22
Debt / EBITDA Ratio
0.260.130.260.290.290.34
Debt / FCF Ratio
-0.305.271.010.571.00
Net Debt / Equity Ratio
0.03-0.010.040.030.030.14
Net Debt / EBITDA Ratio
0.16-0.090.160.130.070.23
Net Debt / FCF Ratio
--0.223.290.430.130.66
Asset Turnover
-0.941.131.191.181.61
Inventory Turnover
-1.541.882.011.782.13
Quick Ratio
-1.371.121.271.371.22
Current Ratio
-4.463.713.363.763.05
Return on Equity (ROE)
-15.01%20.42%25.33%27.32%55.61%
Return on Assets (ROA)
-7.95%13.21%13.81%17.25%31.25%
Return on Invested Capital (ROIC)
12.89%11.35%18.54%20.66%25.17%44.76%
Return on Capital Employed (ROCE)
-13.40%22.40%23.50%31.60%54.30%
Earnings Yield
2.72%6.18%5.69%15.27%10.01%19.78%
FCF Yield
-3.09%0.38%5.19%7.26%10.48%
Dividend Yield
0.16%0.47%0.38%0.92%0.58%0.83%
Payout Ratio
-7.68%5.99%4.99%5.72%2.72%
Buyback Yield / Dilution
-0.01%-----
Total Shareholder Return
0.15%0.47%0.38%0.92%0.58%0.83%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.